Exosens SAS (EXENS) | Financial Analysis & Statements
Exosens SAS Large-cap Industrials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2024Income Metrics
Revenue
100.2M
Gross Profit
59.3M
59.20%
Operating Income
21.2M
21.11%
Net Income
-630.0K
-0.63%
Balance Sheet Metrics
Total Assets
878.8M
Total Liabilities
433.3M
Shareholders Equity
445.6M
Debt to Equity
0.97
Cash Flow Metrics
Operating Cash Flow
20.5M
Free Cash Flow
13.2M
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2024
Annual Income Flow
2025
Exosens SAS Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 383.4M | 468.2M | 291.8M | 200.8M | 166.2M |
| Cost of Goods Sold | 161.1M | 190.7M | 80.3M | 86.8M | 66.1M |
| Gross Profit | 222.3M | 277.5M | 211.5M | 114.0M | 100.0M |
| Gross Margin % | 58.0% | 59.3% | 72.5% | 56.8% | 60.2% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | - | - |
| Other Operating Expenses | 1.6M | 2.1M | 16.1M | 1.9M | 2.0M |
| Total Operating Expenses | 1.6M | 2.1M | 16.1M | 1.9M | 2.0M |
| Operating Income | 80.6M | 102.2M | 54.6M | 33.0M | 32.4M |
| Operating Margin % | 21.0% | 21.8% | 18.7% | 16.4% | 19.5% |
| Non-Operating Items | |||||
| Interest Income | - | - | 528.0K | - | - |
| Interest Expense | - | - | 26.9M | 15.2M | 37.6M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 45.8M | 88.2M | 20.2M | 17.1M | -150.3M |
| Income Tax | 11.6M | 18.0M | 1.8M | 5.9M | -1.3M |
| Effective Tax Rate % | 25.3% | 20.4% | 9.1% | 34.5% | 0.0% |
| Net Income | 30.7M | 42.7M | 18.4M | 11.2M | -149.0M |
| Net Margin % | 8.0% | 9.1% | 6.3% | 5.6% | -89.6% |
| Key Metrics | |||||
| EBITDA | 120.1M | 142.1M | 79.9M | 51.9M | -98.1M |
| EPS (Basic) | €0.60 | €0.84 | €0.24 | €0.37 | €-4.90 |
| EPS (Diluted) | €0.60 | €0.84 | €0.24 | €0.37 | €-4.90 |
| Basic Shares Outstanding | 50916485 | 50764388 | 30387344 | 30387344 | 30387344 |
| Diluted Shares Outstanding | 50916485 | 50764388 | 30387344 | 30387344 | 30387344 |
Income Statement Trend
Exosens SAS Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 68.6M | 117.2M | 15.5M | 29.0M | 15.9M |
| Short-term Investments | 33.3M | 33.0M | 70.0K | 50.0K | 2.4M |
| Accounts Receivable | 73.1M | 71.0M | 69.2M | 32.7M | 35.6M |
| Inventory | 105.1M | 93.0M | 78.5M | 55.7M | 45.0M |
| Other Current Assets | - | - | -1.0K | 2.0K | - |
| Total Current Assets | 280.2M | 314.2M | 192.7M | 144.7M | 112.7M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 128.1M | 104.2M | 51.7M | 36.9M | 25.0M |
| Goodwill | 692.4M | 583.9M | 551.0M | 460.4M | 553.6M |
| Intangible Assets | 225.8M | 204.9M | 202.4M | 181.1M | 38.5M |
| Long-term Investments | - | - | - | - | 0 |
| Other Non-Current Assets | 100.0K | -100.0K | 2.0K | - | 241.0K |
| Total Non-Current Assets | 598.6M | 502.8M | 463.7M | 384.5M | 347.8M |
| Total Assets | 878.8M | 817.0M | 656.4M | 529.3M | 460.5M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 31.2M | 26.0M | 32.3M | 22.9M | 15.9M |
| Short-term Debt | 3.0M | 2.7M | 7.8M | 6.6M | 4.4M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 78.9M | 75.7M | 6.0M | 21.6M | 21.7M |
| Total Current Liabilities | 113.7M | 107.0M | 110.1M | 72.4M | 53.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 13.6M | 8.2M | 303.9M | 242.6M | 203.9M |
| Deferred Tax Liabilities | 34.6M | 20.6M | 17.6M | 14.4M | 0 |
| Other Non-Current Liabilities | 14.2M | 13.3M | 4.9M | 4.9M | 5.6M |
| Total Non-Current Liabilities | 319.6M | 297.4M | 342.3M | 273.7M | 234.9M |
| Total Liabilities | 433.3M | 404.4M | 452.3M | 346.2M | 288.4M |
| Equity | |||||
| Common Stock | 21.6M | 21.6M | 1.9M | 1.9M | 347.5M |
| Retained Earnings | - | - | - | - | -149.0M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 445.6M | 412.6M | 204.1M | 183.1M | 172.1M |
| Key Metrics | |||||
| Total Debt | 16.6M | 10.9M | 311.8M | 249.1M | 208.3M |
| Working Capital | 166.5M | 207.2M | 82.6M | 72.3M | 59.2M |
Balance Sheet Composition
Exosens SAS Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 70.2M | 34.1M | 18.4M | 11.2M | -149.0M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 0 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | 88.8M | 67.7M | 46.2M | 22.6M | 31.6M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | - | - | -68.2M | -33.7M | - |
| Investment Purchases | -69.7M | -31.4M | -69.3M | - | -1.7M |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -121.2M | -71.4M | -167.8M | -33.7M | -21.3M |
| Financing Activities | |||||
| Share Repurchases | -8.8M | -300.0K | 0 | - | - |
| Dividends Paid | -5.1M | - | - | - | - |
| Debt Issuance | - | - | 65.0M | 40.0M | 212.1M |
| Debt Repayment | - | - | -5.4M | -3.1M | -271.3M |
| Financing Cash Flow | -12.8M | 101.1M | 58.4M | 19.9M | -41.9M |
| Free Cash Flow | 107.4M | 98.8M | 50.5M | 25.7M | 42.7M |
| Net Change in Cash | -45.2M | 97.4M | -63.2M | 8.7M | -31.6M |
Cash Flow Trend
Exosens SAS Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
95.15
Forward P/E
28.68
Price to Book
7.25
Price to Sales
6.93
PEG Ratio
28.68
Profitability Ratios
Profit Margin
9.12%
Operating Margin
22.24%
Return on Equity
16.36%
Return on Assets
7.67%
Financial Health
Current Ratio
2.46
Debt to Equity
59.79
Per Share Data
EPS (TTM)
€0.67
Book Value per Share
€8.79
Revenue per Share
€9.23
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| EXENS | 3.2B | 95.15 | 7.25 | 16.36% | 9.12% | 59.79 |
| Legrand S.A | 39.9B | 32.19 | 5.44 | 16.83% | 13.13% | 90.04 |
| Nexans S.A | 6.0B | 28.95 | 3.01 | 11.44% | 4.51% | 94.34 |
| Mersen S.A | 681.3M | 14.20 | 0.87 | 1.51% | 1.19% | 66.20 |
| Gerard Perrier | 311.2M | 18.48 | 2.37 | 13.24% | 5.24% | 33.09 |
| Italy Innovazioni | 30.8M | -111.67 | 7.72 | -6.91% | -378.54% | 22.02 |
Financial data is updated regularly. All figures are in the company's reporting currency.